Bavarian Nordic Announces that Janssen has Received Positive CHMP Opinion for its Investigational Preventative Ebola Vaccine Regimen


Selskabsmeddelelse

Bavarian Nordic Announces that Janssen has Received Positive CHMP Opinion for its Investigational Preventative Ebola Vaccine Regimen

Bavarian Nordic A/S

MEDDELELSE
ID:
122046
Type:
Intern viden
Sprog:
Dansk | Engelsk
Dokument(er):

 
 

TIDSPUNKTER
Offentliggjort:
29.05.2020 | 12:42:08
Registrering:
29.05.2020 | 12:42:12

UDSTEDER
Virksomhed:
Bavarian Nordic A/S
CVR-nr:
LEI:
2138006JCDVYIN6INP51

INDBERETTER
Virksomhed:
GlobeNewswire
CVR-nr.:
UK-02775270



Se den originale selskabsmeddelelse hos Finanstilsynet

Find og læs selskabsmeddelelser fra hele Danmark
Udgiv pressemeddelelser til nul kroner

Scroll to Top